LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis.
Arra M, Swarnkar G, Ke K, Otero JE, Ying J, Duan X, Maruyama T, Rai MF, O'Keefe RJ, Mbalaviele G, Shen J, Abu-Amer Y. · 2020
Read LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis. by Arra M, Swarnkar G, Ke K, Otero JE, Ying J, Duan X, Maruyama T, Rai MF, O'Keefe RJ, Mbalaviele G, Shen J, Abu-Amer Y. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7347613.txt.
Description
Arra and co-authors present a research article in Nature Communications on osteoarthritis. It asks how inflammation helps drive cartilage loss in the joint. The focus is cartilage cells, called chondrocytes, under inflammatory stress. A metabolic shift sits at the center of the work.
The authors show that inflammation switches these cells toward sugar-based energy use. A protein switch called NF-kB drives that change. The shift raises an enzyme, LDHA, which boosts reactive oxygen species in the cell. Those species steady a pro-inflammatory mediator that pushes cartilage breakdown. Blocking this path could slow joint damage, the authors suggest. They name LDHA as a possible drug target. Readers get a clear chain from inflammation to cartilage loss.
Catalog record
| CREATOR | Arra M, Swarnkar G, Ke K, Otero JE, Ying J, Duan X, Maruyama T, Rai MF, O'Keefe RJ, Mbalaviele G, Shen J, Abu-Amer Y. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |